Abstract
Crohn’s disease (CD) and chronic ulcerative colitis (CUC) represent two ends of the spectrum of inflammatory bowel diseases (IBD). Many authors believe there is a complex interaction between genetics, environmental, dietary, and infectious agents that contribute to the onset and progression of both CD and CUC. Because the diseases affect the gut differently and in different places, surgical approaches are distinctly different between them. While in general, the surgical approach to patients with CD is one of conservation, the approach to patients with ulcerative colitis is extirpation of the colon with, in most patients, construction of a pelvic pouch, which facilitates defecation using the normal anatomic pathway. Operations for CD and CUC lend themselves to minimal access surgical techniques. The complications inherent in surgery for IBD are numerous and need to be understood when discussing the goal of surgery for both diseases. The use of anti-TNF biologic therapy has been a great boon to the management of patients with CD, but in patients with ulcerative colitis, its use may complicate definitive surgical management (IPAA). While our understanding of the etiology and medical treatment of both diseases is improving, there is a large and defined role for surgery in the long-term management of patients with both CD and CUC.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Schirbel A, Fiocchi C. Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis. 2010;11(5):266–76.
Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the features, indications, and surgical treatment in 513 consecutive patients affected by Crohn’s disease. Surgery. 1997;122:661–8.
Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn’s disease. Experience with 1,379 patients. Ann Surg. 1991;214:230–8.
Lin MV, Blonski W, Lichtenstein GR. What is the optimal therapy for Crohn’s disease: step-up or top-down? Expert Rev Gastroenterol Hepatol. 2010;4(2):167–80.
Fazio V, Marchetti F, Chruch JM, Goldblum JR. Effect of resection margins on recurrence of Crohn’s disease in small bowel: a randomized controlled trial. Ann Surg. 1996;224:563–73.
Borely NR, Mortensen NJ, Jewell DP. Preventing postoperative recurrence of Crohn’s disease. Br J Surg. 1997;84:1493–502.
McLeod RS, Wolff BG, Steinhart AH, Carryer PW, O’Rourke K, Andrews DF, et al. Risk and significance of endoscopic/radiological evidence of recurrent Crohn’s disease. Gastroenterology. 1997;113(6):1823–7.
Camma C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn’s disease: meta-analysis adjusted for confounding variables. Gastroenterology. 1997;113:1465–73.
Lee EC, Papaionnou N. Minimal surgery for chronic obstruction inpatients with extensive or universal Crohn’s disease. Ann R Coll Surg Engl. 1982;64(4):229–33.
Michelassi F. Side-to-side isoperistaltic strictureplasty for multiple Crohn’s strictures. Dis Colon Rectum. 1996;39:344–9.
Dietz DW, Laureti S, Strong SA, Hull TL, Church J, Remzi FH, et al. Safety and long-term efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg. 2001;192:330–8.
Tichansky D, Cagir B, Yoo E, Marcus SM, Fry RD. Strictureplasty for Crohn’s disease: meta-analysis. Dis Colon Rectum. 2000;43:911–9.
Wibmer AG, Kroesen AJ, Gröne J, Buhr HJ, Ritz JP. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn’s disease – review of the literature. Int J Colorectal Dis. 2010;25(10):1149–57.
Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn’s disease. N Engl J Med. 1999;340(1):1398–405.
Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remzi FH, Fazio VW. Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg. 2004;240(5):825–31.
Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn’s disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59(9):1200–6.
Prabhakar LP, Laramee C, Nelson H, Dozois RR. Avoiding a stoma: role for segmental or abdominal colectomy in Crohn’s colitis. Dis Colon Rectum. 1997;40:71–8.
Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI. Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100(12):2724–9.
Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology. 2001;121(5):1064–72.
Schwartz DA, Herdman CR. Review article: the medical treatment of Crohn’s perianal fistulas. Aliment Pharmacol Ther. 2004;19(9):953–67.
Grimaud JC, Munoz-Bongrand N, Siproudhis L, Abramowitz L, et al. Fibrin glue is effective healing perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2010;138(7):2275–81.
Vitton V, Gasmi M, Barthet M, Desjeux A, Orsoni P, Grimaud JC. Long-term healing of Crohn’s anal fistulas with fibrin glue injection. Aliment Pharmacol Ther. 2005;21(12):1453–7.
O’Connor L, Champagne BJ, Ferguson MA, Orangio GR, Schertzer ME, Armstrong DN. Efficacy of anal fistula plug in closure of Crohn’s anorectal fistulas. Dis Colon Rectum. 2006;49(10):1569–73.
Figg RE, Church JM. Perineal Crohn’s disease: an indicator of poor prognosis and potential proctectomy. Dis Colon Rectum. 2009;52(4):646–50.
Metcalf AM. Elective and emergent operative management of ulcerative colitis. Surg Clin North Am. 2007;87(3):633–41.
Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1,116 patients. Dig Dis Sci. 1993;38(6):1137–46.
Cima RR. Timing and indications for colectomy in chronic ulcerative colitis: surgical consideration. Dig Dis. 2010;28(3):501–7.
Truelove SC, Witts LF. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J. 1955;2:1041–8.
Kulaylat MN, Dayton MT. Ulcerative colitis and cancer. J Surg Oncol. 2010;101(8):706–12.
Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR, et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum. 1992;35(10):950–6.
Gorfine SR, Bauer JJ, Harris MT, Kreel I. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted? Dis Colon Rectum. 2000;43(11):1575–81.
Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003;125(5):1311–9.
Odze RD, Farraye FA, Hecht JL, et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004;2:534–41.
Browning SM, Nivatvongs S. Intraoperative abandonment of ileal pouch to anal anastomosis – the Mayo Clinic experience. J Am Coll Surg. 1998;186(4):441–5. discussion 445–446.
Cima RR, Young-Fadok TM, Pemberton JH. Chapter 27 Procedures for Ulcerative Colitis. In: Souba WW, Fink MP, Jurkovich GJ, et al., editors. ACS Surgery: Principles & Practice, Alimentary Tract and Abdomen, vol. 4. New York: WebMD Inc; 2005. p. 674.
Dunker MS, Bemelman WA, Slors JFM, et al. Functional outcome, quality of life, body image, and cosmesis in patients after laparoscopic-assisted and conventional restorative proctocolectomy: a comparative study. Dis Colon Rectum. 2001;44:1800–7.
Larson DW, Cima RR, Dozois EJ, Davies M, Piotrowicz K, Barnes SA, et al. Safety, feasibility, and short-term outcomes of laparoscopic ileal-pouch-anal anastomosis: a single institutional case-matched experience. Ann Surg. 2006;243(5):667–70. discussion 670–672.
Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1,310 patients. Br J Surg. 1998;85:800–3.
Marcello PW, Robert PL, Schoetz Jr DJ, et al. Long-term results of ileoanal pouch procedure. Arch Surg. 1993;128:500–3.
Romanos J, Samarasekera DN, Stebbing JF, et al. Outcomes of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience. Br J Surg. 1997;84:814–8.
Hahnloser D, Pemberton JH, Wolff BG, et al. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg. 2007;94:333–40.
Bullard KM, Madoff RD, Gemlo BT. Is ileoanal pouch function stable with time? Results of a prospective audit. Dis Colon Rectum. 2002;45:299–304.
Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomoses complications and function in 1,005 patients. Ann Surg. 1995;222:120–7.
Fazio VW, O’Riordan MG, Lavery IC, et al. Long-term functional outcome and quality of life after stapled restorative proctocolectomy. Ann Surg. 1999;230:575–84.
Galandiuk S, Scott NA, Dozois RR, et al. Ileal pouch-anal anastomosis: reoperation for pouch-related complications. Ann Surg. 1990;212:446–52.
MacLean AR, Cohen Z, MacRae HM, O’Connor BI, Mukraj D, Kennedy ED, et al. Risk of small bowel obstruction after the ileal pouch-anal anastomosis. Ann Surg. 2002;235(2):200–6.
Indar AA, Efron JE, Young-Fadok TM. Laparoscopic ileal pouch-anal anastomosis reduces abdominal and pelvic adhesions. Surg Endosc. 2009;23(1):174–7.
Ferrante M, Declerck S, De Hertogh G, Van Assche G, Geboes K, Rutgeerts P, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2008;14(1):20–8.
Yu ED, Shao Z, Shen B. Pouchitis. World J Gastroenterol. 2007;13(42):5598–604.
Holubar SD, Cima RR, Sandborn WJ, Pardi DS. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2010;(6):CD001176.
Sugarman HJ, Sugerman EL, Meador JG, et al. Ileal pouch anal anastomosis without ileal diversion. Ann Surg. 2000;232:530–41.
Heuschen UA, Hinz U, Allemeyer EH, et al. One- or two-stage procedure for restorative proctocolectomy: rationale for a surgical strategy in ulcerative colitis. Ann Surg. 2002;234:788–94.
Grobler SP, Hosie KB, Keighly MRB. Randomized trial of loop ileostomy in restorative proctocolectomy. Br J Surg. 1992;79:903–6.
Williamson MER, Lewis WG, Sagar PM, et al. One-stage restorative proctocolectomy without temporary ileostomy for ulcerative colitis: a note of caution. Dis Colon Rectum. 1997;40:1019–22.
Tan HT, Connolly AB, Morton D, et al. Results of restorative proctocolectomy in the elderly. Int J Colorectal Dis. 1997;12:319–22.
Olsen KØ, Joelsson M, Laurberg S, et al. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg. 1999;86:493–5.
Lepistö A, Sarna S, Tiitinen A, Järvinen HJ. Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg. 2007;94(4):478–82.
Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut. 2006;55(11):1575–80.
Mortier PE, Gambiez L, Karoui M, Cortot A, Paris JC, Quandalle P, et al. Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol. 2006;30(4):594–7.
Olsen KØ, Juul S, Bülow S, Järvinen HJ, Bakka A, Björk J, et al. Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg. 2003;90(2):227–31.
Scott HJ, McLeod RS, Blair J, et al. Ileal pouch-anal anastomosis: pregnancy, delivery and pouch function. Int J Colorectal Dis. 1996;11:84–7.
Seligman NS, Sbar W, Berghella V. Pouch function and gastrointestinal complications during pregnancy after ileal pouch-anal anastomosis. J Matern Fetal Neonatal Med. 2011;24(3):525–30.
Farouk R, Pemberton JH, Wolff BG, et al. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg. 2000;231:919–26.
Ferrante M, D’Hoore A, Vermeire S, et al. Corticosteroids but not infliximab increase short-term postoperative infectious complication in patients with ulcerative colitis. Inflamm Bowel Dis. 2009;15:1062–70.
Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg. 2007;204:956–63.
Mor IJ, Vogel JD, Moreira Ada L, et al. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum. 2008;51:1202–10.
Kunitake H, Hodin R, Shellito PC, et al. Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointestinal Surg. 2008;12:1730–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cima, R.R., Pemberton, J.H. (2012). Surgical Management of Crohn’s Disease and Ulcerative Colitis. In: Baumgart, D. (eds) Crohn's Disease and Ulcerative Colitis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-0998-4_45
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0998-4_45
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-0997-7
Online ISBN: 978-1-4614-0998-4
eBook Packages: MedicineMedicine (R0)